Literature DB >> 18413216

Placental weight and placental weight-to-birth weight ratio are increased in diet- and exercise-treated gestational diabetes mellitus subjects but not in subjects with one abnormal value on 100-g oral glucose tolerance test.

Mert Kucuk1, Fadime Doymaz.   

Abstract

The aim of the present study was to determine whether the placental weight and placental weight-to-birth weight ratio (PW/BW) increased in pregnant women with one abnormal value (OAV) on 100-g oral glucose tolerance test (OGTT) and diet- and exercise-treated, non-insulin-requiring gestational diabetes mellitus (GDM) subjects. The 50-g glucose challenge test (GCT) was administered to 324 pregnant women. Women with abnormal 50-g test received a 100-g, 3-h OGTT using National Diabetes Data Group criteria. Women with GDM and OAV were treated with diet and exercise. Twenty subjects who required insulin or met exclusion criteria were excluded from the study. After the exclusion of 20 subjects, the GDM group consisted of 30 (9.7%) pregnant women and the OAV group consisted of 32 (9.9%) pregnant women. The control group consisted of 242 pregnant women. Birth weight (GDM: 3288.3+/-364.2 g; OAV: 3278.1+/-409.9 g; control group: 3270.6+/-346.5 g) did not differ significantly between groups (P>.05). Significantly higher placental weights (GDM: 694.8+/-152.1 g; OAV: 622.2+/-105.3 g; control group: 610.2+/-116.6 g; P<.01) and PW/BW (GDM: 0.21+/-0.03; OAV: 0.193+/-0.04; control group: 0.188+/-0.04; P<.01) were observed in GDM group compared to OAV and control group. No significant difference was found for OAV group in terms of placental weight and PW/BW compared to the control group. Our data indicated that women with OAV delivered infants and placenta of similar weight to those of normal pregnancies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413216     DOI: 10.1016/j.jdiacomp.2007.04.002

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  8 in total

Review 1.  The placenta and gestational diabetes mellitus.

Authors:  M Gauster; G Desoye; M Tötsch; U Hiden
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

2.  Melatonin Administration Prevents Placental and Fetal Changes Induced by Gestational Diabetes.

Authors:  Ismaela Maria Ferreira de Melo; Cintia Giselle Martins Ferreira; Érique Ricardo Alves; Carolline Guimarães D'Assunção; Clovis José Cavalcanti Lapa Neto; Yuri Mateus Lima de Albuquerque; Valéria Wanderley Teixeira; Álvaro Aguiar Coelho Teixeira
Journal:  Reprod Sci       Date:  2022-01-13       Impact factor: 3.060

3.  Maternal psychosocial stress during pregnancy and placenta weight: evidence from a national cohort study.

Authors:  Marion Tegethoff; Naomi Greene; Jørn Olsen; Andrea H Meyer; Gunther Meinlschmidt
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

Review 4.  Role of nitric oxide in placental vascular development and function.

Authors:  B J Krause; M A Hanson; P Casanello
Journal:  Placenta       Date:  2011-07-27       Impact factor: 3.481

5.  Expression of ABC Efflux transporters in placenta from women with insulin-managed diabetes.

Authors:  Gregory J Anger; Alex M Cressman; Micheline Piquette-Miller
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  Effects of Diet and Metformin on placental morphology in Gestational Diabetes Mellitus.

Authors:  Rabia Arshad; Muhammad Adnan Kanpurwala; Nasim Karim; Jahan Ara Hassan
Journal:  Pak J Med Sci       Date:  2016 Nov-Dec       Impact factor: 1.088

Review 7.  The diagnostic indicators of gestational diabetes mellitus from second trimester to birth: a systematic review.

Authors:  Amanda Henry; Alec Welsh; Daria Di Filippo; Thiyasha Wanniarachchi; Daniel Wei; Jennifer J Yang; Aoife Mc Sweeney; Alys Havard
Journal:  Clin Diabetes Endocrinol       Date:  2021-10-11

Review 8.  Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming.

Authors:  Li-Tung Huang; Chih-Sung Hsieh; Kow-Aung Chang; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2012-11-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.